Congratulations! Daniella Schwartz, MD, 2024 ICIS-Regeneron New Investigator Award for Excellence in Cytokine & Interferon Research Winner

Dr. Schwartz graduated with a B.A. in Biochemistry and French from Rice University and received an M.D. from the Wake Forest University School of Medicine in 2007. She completed her internal medicine residency training at Virginia Commonwealth University in 2010, after which she served as a chief medical resident. She completed a fellowship in clinical rheumatology at the National Institute of Arthritis and Musculoskeletal and Skin Diseases and was subsequently promoted to Metzger Scholar in Translational Research, where she did a postdoctoral fellowship in the lab of Dr. John O’Shea. In 2018, she was recruited to the NIAID intramural research program as an Assistant Clinical Investigator. In 2022, Dr. Schwartz was recruited to the University of Pittsburgh, where she is currently an Assistant Professor in the Division of Rheumatology and Clinical Immunology. Her lab investigates genetic and epigenetic mechanisms of immune dysregulation, with a focus on interleukin 9 and inborn errors of immunity. She is the co-director of the UPMC Autoinflammatory Disease Center of Excellence and Director of Research for the Pittsburgh Immunogenetics Discovery Center (PIDC) to study inborn errors of immunity. She has authored numerous peer-reviewed publications and was awarded the NPF Robertson Fellowship and 2020 American Society of Clinical Investigation Young Physician Scientist Award.